Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
Cash Flows From Operating Activities | |||||
Net Income | -27,790 | -11,618 | -36,529 | -28,998 | -31,440 |
Depreciation Amortization | 3,539 | 3,692 | 3,631 | 3,133 | 1,990 |
Accounts receivable | N/A | 243 | 3,891 | -6,860 | -1,224 |
Other Working Capital | 3,049 | 705 | 7,929 | -13,667 | 71,091 |
Other Operating Activity | -9,451 | 7,613 | -2,492 | 7,928 | 4,035 |
Operating Cash Flow | $-30,653 | $635 | $-23,570 | $-38,464 | $44,452 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -42 | -80 | N/A | N/A | N/A |
PPE Investments | -1,890 | -2,068 | -5,703 | -7,855 | -6,122 |
Other Investing Activity | -170 | -138 | -165 | -137 | -52 |
Investing Cash Flow | $-2,102 | $-2,286 | $-5,868 | $-7,992 | $-6,174 |
Cash Flows From Financing Activities | |||||
Debt Issued | 66,780 | N/A | N/A | N/A | N/A |
Common Stock Issued | 112 | 26,558 | 20,927 | 501 | 293 |
Financing Cash Flow | $66,892 | $26,558 | $20,927 | $501 | $293 |
Exchange Rate Effect | 226 | 127 | -388 | 589 | 99 |
Beginning Cash Position | 52,035 | 27,001 | 35,900 | 81,266 | 42,596 |
End Cash Position | 86,398 | 52,035 | 27,001 | 35,900 | 81,266 |
Net Cash Flow | $34,363 | $25,034 | $-8,899 | $-45,366 | $38,670 |
Free Cash Flow | |||||
Operating Cash Flow | -30,653 | 635 | -23,570 | -38,464 | 44,452 |
Capital Expenditure | -1,890 | -2,068 | -5,705 | -7,855 | -6,195 |
Free Cash Flow | -32,543 | -1,433 | -29,275 | -46,319 | 38,257 |